Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gero Knittel

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery|February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCFelix Dietlein, Lisa Thelen, Mladen Jokic, et al.
Cancers|July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse ModelMaximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Blood|June 27, 2022
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaGrace M Pindzola, Raud Razzaghi, Rachel N Tavory, et al.
Theranostics|September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
European Journal of Haematology|February 19, 2024
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCRJan-Michel Heger, Yannick d'Hargues, Fanni Kleinert, et al.
Blood|November 24, 2020
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasMaurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Cell Reports. Medicine|February 10, 2024
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz, Tobias Riet, Daniel Felix Neureuther, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|December 21, 2023
Mouse models of diffuse large B cell lymphomaAreya Tabatabai, Aastha Arora, Svenja Höfmann, et al.
Cancer Discovery|February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCFelix Dietlein, Lisa Thelen, Mladen Jokic, et al.
Cancers|July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse ModelMaximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Blood|June 27, 2022
Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphomaGrace M Pindzola, Raud Razzaghi, Rachel N Tavory, et al.
Theranostics|September 20, 2019
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53Maximiliane Schuldner, Bastian Dörsam, Olga Shatnyeva, et al.
European Journal of Haematology|February 19, 2024
Noninvasive minimal residual disease assessment in relapsed/refractory large B-cell lymphoma using digital droplet PCRJan-Michel Heger, Yannick d'Hargues, Fanni Kleinert, et al.
Blood|November 24, 2020
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomasMaurice Reimann, Jens Schrezenmeier, Paulina Richter-Pechanska, et al.
Blood Advances|December 7, 2023
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphomaRuth Flümann, Julia Hansen, Jörn Meinel, et al.
Cancer Discovery|October 20, 2022
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal LymphomasLeandro Venturutti, Martin A Rivas, Benedikt W Pelzer, et al.
Cell Reports. Medicine|February 10, 2024
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz, Tobias Riet, Daniel Felix Neureuther, et al.
Pageof 4